# A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers

> **NCT00614016** · PHASE1 · COMPLETED · sponsor: **HemaQuest Pharmaceuticals Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sodium ST20

## Key facts

- **NCT ID:** NCT00614016
- **Lead sponsor:** HemaQuest Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614016, "A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00614016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*